FRESH TRACKS THERAPEUTICS IN (FRTX) Stock Cash Flow
NASDAQ:FRTX - Nasdaq - US10802T2042 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.98M | -21.10M | -39.47M | -20.91M | -23.88M | |||
| Depreciation Amortization | 40.00K | 30.00K | 20.00K | 10.00K | 30.00K | |||
| Change In Working Capital | 920.00K | -480.00K | -560.00K | -1.65M | -13.63M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | N/A | |||
| Other non cash items | 2.22M | 2.22M | 3.86M | 2.52M | 1.50M | |||
| OPERATING CASH FLOW | -5.80M | -19.34M | -36.15M | -20.03M | -35.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -50.00K | -40.00K | -20.00K | -10.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 4.50M | 32.52M | |||
| INVESTING CASH FLOW | N/A | -50.00K | -40.00K | 4.48M | 32.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 440.00K | 2.59M | |||
| Stock Issued/Repurchased | 6.57M | 1.23M | 33.00M | 38.00M | 50.00K | |||
| Other Financing Activity | -10.00K | -60.00K | -50.00K | N/A | 0.00 | |||
| FINANCING CASH FLOW | 6.57M | 1.18M | 32.95M | 38.44M | 2.64M | |||
| CHANGE IN CASH | 770.00K | -18.21M | -3.24M | 22.89M | -830.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.80M | -19.34M | -36.15M | -20.03M | -35.98M | |||
| Capital Expenditure | N/A | -50.00K | -40.00K | -20.00K | -10.00K | |||
| FREE CASH FLOW | -5.80M | -19.39M | -36.19M | -20.05M | -35.99M | |||
All data in USD